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Highly topographic organization of neural circuits
exists for the regulation of various brain functions
in corticobasal ganglia circuits. Although neural
circuit-specific refinement during synapse develop-
ment is essential for the execution of particular neu-
ral functions, the molecular and cellular mechanisms
for synapse refinement are largely unknown. Here,
we show that protocadherin 17 (PCDH17), one of
the nonclustered d2-protocadherin family members,
is enriched along corticobasal ganglia synapses in a
zone-specific manner during synaptogenesis and
regulates presynaptic assembly in these synapses.
PCDH17 deficiency in mice causes facilitated pre-
synaptic vesicle accumulation and enhanced synap-
tic transmission efficacy in corticobasal ganglia
circuits. Furthermore, PCDH17/ mice exhibit anti-
depressant-like phenotypes that are known to be
regulated by corticobasal ganglia circuits. Our find-
ings demonstrate a critical role for PCDH17 in the
synaptic development of specific corticobasal
ganglia circuits and suggest the involvement of
PCDH17 in such circuits in depressive behaviors.
INTRODUCTION
The basal ganglia comprise a group of subcortical nuclei that
includes the striatum, the globus pallidus, and the substantia
nigra. These nuclei receive input from the cerebral cortex and
send output to the thalamus, constituting corticobasal ganglia-
thalamocortical loops that govern various brain functions associ-
ated with complex motor action, reward-based learning, cogni-tion, emotion, and motivation (Redgrave et al., 2010; Utter and
Basso, 2008). To perform these different functions, individual
cortical areas project to discrete regions of the basal ganglia in
a highly topographic manner (Alexander and Crutcher, 1990;
Redgrave et al., 2010). Thus, prefrontal cortical areas provide
input to anterior regions of the striatum; sensorimotor cortical
areas project to central dorsolateral regions; and the parietal
cortex provides input to more posterior regions (Draganski
et al., 2008; Takada et al., 2001;Wiesendanger et al., 2004). Dys-
functions along the corticobasal ganglia circuit lead to neurolog-
ical and neuropsychiatric diseases, including Parkinson’s
disease, obsessive-compulsive disorder, schizophrenia, and
depressive disorder (Krishnan and Nestler, 2008; Simpson
et al., 2010; Utter and Basso, 2008). Therefore, clarification of
the precise topography and pathway-specific synapse develop-
ment in corticobasal ganglia circuits is crucial for understanding
the mechanisms that regulate respective brain functions.
The anatomical topography of neural circuits generally em-
phasizes distinct functional units. Functional establishment of
this topography requires circuit-specific differentiation and
refinement of synapses. Recent studies suggest that synapse
development in individual circuits is organized by various types
of synaptic interaction molecules (Williams et al., 2010). Pro-
teins of the cadherin superfamily, including the protocadherin
family, are thought to participate in synapse-specific interac-
tions (Shapiro and Colman, 1999; Williams et al., 2011; Zipursky
and Sanes, 2010). This family of proteins is expressed in synap-
tic junctions between different types of neurons in neural
circuits (Kim et al., 2007; Redies, 2000). Owing to their highly
selective adhesive interactions, cadherin-catenin complexes
are required for both pre- and postsynaptic development
(Arikkath and Reichardt, 2008; Togashi et al., 2002). Although
some cadherin members are expressed in specific zones of
the basal ganglia (Hertel et al., 2008), their roles in circuit-
specific synaptic development and their physiological signifi-
cance remain unclear.Neuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc. 839
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Protocadherin 17 in Corticobasal Ganglia CircuitsAfter enormous numbers of synapses are formed, subsequent
synaptic refinement is an essential step for the completion of
functional neural circuits. Recently, molecular mechanisms that
control recruitment and localization of synaptic vesicles (SVs)
to presynaptic locations have attracted much attention (Goda
and Davis, 2003; Ziv and Garner 2004). Furthermore, dynamic
regulation of presynaptic SV by neural activity is thought to be
a fundamental process involved in presynaptic plasticity (Hopf
et al., 2002; Regehr, 2012). Several lines of evidence suggest
that trans-synaptic cell adhesion molecules, such as cadherin
superfamily proteins, SynCAM family proteins, and the neu-
rexin-neuroligin complex, help trigger presynaptic assembly
(Ziv and Garner, 2004). Ablation of N-cadherin or b-catenin in
neurons results in reduced SV assembly in presynaptic terminals
(Bamji et al., 2003; Stan et al., 2010), suggesting that cadherin-
catenin adhesive complexes play a pivotal role in localizing
SVs to presynaptic compartments (Arikkath and Reichardt,
2008). Although some protocadherins are thought to participate
in presynaptic assembly, roles of individual protocadherin
members in vivo in synapse refinement and function are not
well understood.
In the present study, we addressed the biological significance
of PCDH17, a nonclustered d2-protocadehrin family member.
Our results indicate that PCDH17 plays a crucial role in the regu-
lation of presynaptic vesicle assembly in corticobasal ganglia
circuits. Furthermore, PCDH17 deficiency leads to altered pre-
synaptic function in the corticostriatal pathway. We also
observed antidepressant-like phenotypes in PCDH17/ mice.
These results provide new insights into themechanisms underly-
ing the synaptic development of specific corticobasal ganglia cir-
cuits and the physiological role of depression-related behaviors.
RESULTS
PCDH17 Is Expressed along Corticobasal Ganglia
Circuits in a Topographic Manner
PCDH17, a member of the nonclustered d2-protocadherin fam-
ily, is a transmembrane protein that displays the six extracellular
cadherin domains and two cytoplasmic motifs, CM1 and CM2,
that are conserved in this family (Redies et al., 2005; Figure 1A).
Immunoblot analysis showed that mouse PCDH17 is specif-
ically expressed in the brain (Figure 1B) and that its expression
level is high during early synaptogenesis (postnatal weeks 1–2)
(Figure 1C). At postnatal day 10, immunohistochemistry re-
vealed that PCDH17 is distributed in the striatum, lateral globus
pallidus (LGP), medial globus pallidus (MGP), and substantia
nigra pars reticulata (SNr) of the basal ganglia in a highly
zone-specific manner (Figure 1D). To precisely evaluate the
expression pattern of PCDH17 in basal ganglia, we co-stained
PCDH17 and DARPP-32, which are expressed in striatal me-
dium spiny neurons (MSNs) and which are distributed in almost
all basal ganglia nuclei. It was found that PCDH17 is distributed
in anterior regions of the striatum, including the anterior dorsal
striatum and the anterior nucleus accumbens, inner regions of
the LGP and MGP, and posterior regions of the SNr (Figure 1E
and see Figure S1A available online). To characterize PCDH17-
expressing cells along the corticobasal ganglia circuits, we
performed X-gal staining of brain slices from PCDH17 heterozy-840 Neuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc.gous mice expressing LacZ under control of the PCDH17 pro-
moter (Figure S3A). b-gal-positive neurons were localized in
the anterior striatum, inner LGP, inner MGP, and posterior
SNr. This staining pattern is virtually identical to that observed
with PCDH17 antibody (Figures 1F and S1B). Costaining of
b-gal and DARPP-32 revealed that anterior striatal MSNs ex-
press PCDH17 (data not shown). b-gal-positive neurons were
also identified in the cerebral cortex; The b-gal signal was stron-
gest in the medial prefrontal cortex, high in the cingulate cortex
and motor cortex, and moderate to low in the somatosensory
cortex and posterior part of the cortex (Figures 1G and S1B).
In addition, the b-gal signal was strong in layer V neurons,
including those that project to MSNs (Figures 1G and S1B),
although it was also strongly expressed in layer II/III neurons
of the medial prefrontal cortex. We next investigated whether
PCDH17-expressing regions were anatomically connected in
the corticobasal ganglia pathway using the fluorescent neuronal
tracer, cholera toxin subunit B (CTb) conjugated to Alexa Fluor
488. When CTb was injected into the anterior striatum for retro-
grade tracing, medial prefrontal cortical neurons were mostly
labeled (Figure S1C). CTb can also be used for anterograde
tracing (Angelucci et al., 1996). Accordingly, double fluores-
cence histochemistry with CTb and immunostained PCDH17
showed that CTb anterograde-labeled anterior striatal axon ter-
minals accurately identify PCDH17-positive zones in basal
ganglia (Figure S1D). In addition, the Gene Expression Nervous
System Atlas (GENSAT) database (http://www.gensat.org/
index.html) contains PCDH17 promoter-driven EGFP-express-
ing transgenic mice. Their EGFP expression patterns are similar
to PCDH17 expression patterns in basal ganglia, reflecting
PCDH17-expressing pathways (Figure S1E). Overall, PCDH17
was expressed at the high level in both pre- and post-
synaptic neurons in the medial prefrontal cortex and anterior
striatum, as well as the inner LGP, inner MGP, and posterior
SNr. In other words, PCDH17 is expressed along the anatomi-
cally connected corticobasal ganglia pathways in a highly
topographic manner.
Complementary Expression Patterns of PCDH17 and
PCDH10 in Corticobasal Ganglia Circuits
Because protocadherin 10 (PCDH10), another d2-protocadherin
family member, is highly expressed in the striatum (Aoki et al.,
2003), we next compared expression patterns of both of these
proteins in basal ganglia. Double immunostaining of PCDH17
and PCDH10 showed that while PCDH17 is distributed in the
anterior striatum, PCDH10 is distributed in the posterior striatum
(Figure 2A). Therefore, expression of the two protocadherins was
complementary along the anteroposterior axis. Their distribu-
tions are also complementary in the LGP and MGP; PCDH17
displays an inner distribution, but PCDH10 displays an outer dis-
tribution within these regions (Figure 2A). Furthermore, in
contrast to the distribution of PCDH17 in the posterior SNr,
PCDH10 is distributed in the anterior SNr (Figure 2A). Double-
fluorescent in situ hybridization demonstrated that both
PCDH17 and PCDH10 mRNAs also exhibit complementary
expression patterns in basal ganglia (Figure S2). Thus, these
findings indicate that PCDH17 and PCDH10 delineate topo-
graphic features of this pathway.
Figure 1. Expression of PCDH17 along Corticobasal Ganglia Circuits in a Topographic Manner
(A) A schematic representation of PCDH17 domain structure. ss, signal sequence; CA, cadherin-like domain; TM, transmembrane domain; CM1/2, conserved
motifs among the d-protocadherin family; aa, amino acid.
(B) Immunoblotting for PCDH17 in P10 mouse tissue lysates (30 mg).
(C) Immunoblotting for PCDH17, PCDH10 and N-cadherin in mouse brain lysates at the indicated ages. a-tubulin was used as a loading control.
(D) Immunostaining for PCDH17 in a sagittal brain section of a P10 mouse.
(E) Double staining for PCDH17 and DARPP-32 in a basal ganglia sagittal section of a P10 mouse.
(F) X-gal staining for PCDH17 promoter-driven b-gal in a sagittal brain section of a P10 PCDH17LacZ/+ mouse.
(G) X-gal staining for PCDH17 promoter-driven b-gal in coronal brain sections of a P10 PCDH17LacZ/+mouse. Higher-magnification images of each cortical area
are indicated on the right.
Scale bars represent 1 mm (D, F, and G) and 0.5 mm (E). LGP, lateral globus pallidus; MGP, medial globus pallidus; mPFC, medial prefrontal cortex; M1, primary
motor cortex; M2, secondary motor cortex; NA, nucleus accumbens; Ob, olfactory bulb; SNr, substantia nigra pars reticulata; Str, striatum; S1, primary
somatosensory cortex. See also Figure S1.
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Protocadherin 17 in Corticobasal Ganglia CircuitsWe next compared the protein expression patterns of
PCDH17 and PCDH10 in the cerebral cortex and thalamus,
particularly in the prefrontal cortex and the mediodorsal thal-
amus, as these regions are anatomically and functionally
incorporated into the corticobasal ganglia-thalamocortical loops
(McCracken and Grace, 2009; McFarland and Haber, 2002). Inthe prefrontal cortex, while PCDH17 is distributed in the medial
prefrontal cortex, PCDH10 expression is higher in the orbito-
frontal cortex, indicating partially complementary expression
patterns (Figure 2B). In subregions of the mediodorsal thalamus,
PCDH17 and PCDH10 expression are also expressed in a some-
what complementary manner (Figure 2C). Thus, expression ofNeuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc. 841
Figure 2. Complementary Expression Pattern between PCDH17 and PCDH10 in Corticobasal Ganglia Circuits
(A–C) Double staining for PCDH17 and PCDH10 in P10mice in a basal ganglia sagittal section (A), prefrontal cortex coronal section (B), andmediodorsal thalamus
coronal section (C). Scale bars represent 0.5 mm. CL, centrolateral thalamic nucleus; CM, central medial thalamic nucleus; CMD, central mediodorsal thalamus;
IMD, intermediodorsal thalamus; LGP, lateral globus pallidus; LHb, lateral habenula; LMD, lateral mediodorsal thalamus; MGP, medial globus pallidus; MHb,
medial habenula; MMD, medial mediodorsal thalamus; mPFC, medial prefrontal cortex; M2, secondary motor cortex; OFC, orbitofrontal cortex; PC, paracentral
thalamic nucleus; PV, paraventricular thalamic nucleus; SNr, substantia nigra pars reticulata. See also Figure S2.
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Protocadherin 17 in Corticobasal Ganglia CircuitsPCDH17 and PCDH10 are largely complementary throughout
the corticobasal ganglia-thalamocortical loop circuits in a highly
topographic manner. We note that expression of PCDH17 and
PCDH10 partially overlaps in some cortical and thalamic areas,
which could explain the presence of integrative and converging
trans-circuits in these areas (Draganski et al., 2008).
PCDH17 Is Localized at Perisynaptic Sites in Basal
Ganglia
We examined the subcellular localization of PCDH17 in basal
ganglia using high-resolution structured illumination microscopy
(SIM) to acquire 3D images with resolution approaching 100 nm
(Schermelleh et al., 2008). We performed immunostaining of
PCDH17 in addition to VGLUT1 and PSD-95, markers of the
pre- and postsynaptic compartments of corticostriatal excitatory
synapses, respectively. SIM images of the anterior striatum re-
vealed that PCDH17 proteins are present in punctate structures,
a subset of which is associated with VGLUT1 and PSD-95 (Fig-
ure 3A). 3D reconstructed images showed that PCDH17 is local-
ized next to juxtaposed pairs of VGLUT1 and PSD-95 (Figure 3A).
Using stochastic optical reconstruction microscopy (STORM),842 Neuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc.another new, super-resolution imaging technique, distributions
of synaptic proteins can be measured with nanometer precision
(Dani et al., 2010). Two-color 2D STORM images clearly resolved
the PCDH17/VGLUT1 protein distribution and the PCDH17/
PSD-95 protein distribution as adjacent, but discrete molecular
structures (Figure 3B). We next used pre-embedding immuno-
gold electron microscopy to analyze PCDH17 ultrastructural
localization in asymmetric synapses of MSNs, most of which
are thought to be corticostriatal excitatory synapses (Surmeier,
et al., 2007). In MSNs of the anterior striatum, immunogold
particles indicating PCDH17 localization were observed in pre-
synaptic boutons, dendritic shafts, and dendritic spines, where
the majority of particles were attached to the plasma membrane
(Figures 3C and 3D). To quantify the distribution of PCDH17 at
synapses in detail, we divided each synapse cross-section into
central, peripheral, perisynaptic, and extrasynaptic regions,
and scored each region for immunogold particles (Nakazawa
et al., 2006). Many of the membrane-associated particles were
perisynaptically localized at both pre- and postsynaptic sites in
an apposed manner (Figures 3C and 3D). Furthermore, in the in-
ner regions of the LGP, 3D-SIM imaging revealed that PCDH17
Neuron
Protocadherin 17 in Corticobasal Ganglia Circuitspuncta are associated with VGAT and gephyrin, markers of the
pre- and postsynaptic compartments of striatopallidal inhibitory
synapses, respectively (Figure 3E). STORM imaging also clearly
resolved the PCDH17/VGAT protein distribution and the
PCDH17/gephyrin protein distribution as neighboring molecular
structures (Figure 3F). At the ultrastructural level, PCDH17 parti-
cles were mostly located at perisynaptic sites in inhibitory sym-
metric synapses (Figures 3G and 3H). These findings indicate
that PCDH17 is localized in both excitatory and inhibitory perisy-
naptic sites in basal ganglia nuclei.
PCDH17-Mediated Intercellular Homophilic Interaction
Given that most cadherin family members exhibit calcium-
dependent homophilic interactions, we then investigated
PCDH17-mediated homophilic interactions using biochemical
assays. We prepared a soluble form of the Fc-fused extracel-
lular domain of PCDH17 (PCDH17E-Fc) with independently
prepared myc-tagged, full-length PCDH17 (PCDH17-myc) at
various Ca2+ concentrations (Figure 4A). Immunoblotting re-
vealed that PCDH17E-Fc interacted with PCDH17-myc in solu-
tions at Ca2+ concentration >1 mM (Figure 4B). This interaction
was abolished in the presence of the calcium chelator, EDTA,
further supporting the conclusion that the observed homophilic
binding is calcium-dependent (Figure 4B). Furthermore,
PCDH17 did not exhibit heterophilic interactions with PCDH10
(Figure 4C). The specificity of intercellular interactions of
PCDH17 was also examined using CHO cells stably expressing
PCDH17 or PCDH10. In a coculture system with these stable
cell lines, PCDH17 was localized at contact sites between
PCDH17-expressing cells, but not at contact sites with cells ex-
pressing PCDH10 (Figure 4D). In addition, we also performed
coculture experiments between cortical neurons expressing
PCDH17-EGFP and CHO cells expressing either PCDH17-
myc or PCDH10-myc. A significant portion of PCDH17-EGFP
in neurons was localized next to PCDH17-myc in CHO cells at
contact points, but not PCDH10-myc in CHO cells (Figure 4E).
Taking these results together with the finding that PCDH17 is
mainly localized at both excitatory and inhibitory perisynaptic
sites (Figure 3), we conclude that PCDH17 mediates homo-
philic intercellular interactions at synapses in basal ganglia
(Figure 4F).
PCDH17–/– Mice Show Increased Numbers of Synaptic
Vesicles at Presynaptic Terminals in Zone-Specific
Basal Ganglia Pathways
To examine the physiological role of PCDH17, we generated
PCDH17/ mice (Figure S3A). The success of the procedure
was confirmed by Southern blot (data not shown) and PCR anal-
ysis (Figure S3B). We confirmed the absence of the PCDH17
protein in PCDH17/ mice by immunoblotting and immuno-
staining (Figures S3C and S3D). The loss of PCDH17 in
PCDH17/mice was also confirmed by immunoelectron micro-
scopy (Figure S3E). Quantitative analysis in the anterior striatum
verified a 96% reduction in numbers of immunogold particles in
comparison with wild-type mice. The numbers of PCDH17/
mice produced followed a Mendelian segregation pattern and
these mice attained normal body size and appeared healthy
(data not shown). Histological analysis using Nissl-stained coro-nal sections from the central nervous system from PCDH17/
mice did not show any gross abnormalities in cytoarchitecture
(Figure S3F). In addition, the absence of PCDH17 did not
affect the expression of synapse-specific markers, including
N-cadherin, Synaptophysin, VGLUT1, PSD-95, NMDA receptor
subunits, and AMPA receptor subunits in the anterior and poste-
rior striatum (Figure S3G).
We examined whether axonal projections were abrogated in
the absence of PCDH17. Immunostaining analyses showed
that PCDH17 deficiency did not affect overall axonal projec-
tions, including corticothalamic/thalamocortical projections,
striatopallidal/striatonigral projections, and nigrostriatal pro-
jections (Figures S4A and S4B). Therefore, in contrast to
the abnormal axonal projection phenotypes observed in
PCDH10/ mice (Uemura et al., 2007), the overall circuitry
in basal ganglia appeared to be intact in PCDH17/ mice.
We next evaluated whether ablation of PCDH17 affected the
topographic connections within the corticobasal ganglia
circuits. In retrograde tracing, local injections of CTb-Alexa
Fluor 488 into the anterior striatum and CTb-Alexa Fluor 555
into the posterior striatum resulted in the labeled signals in
medial prefronatal cortex and motor cortex, respectively, in
both wild-type and PCDH17/ mice (Figure S4C). Thus,
PCDH17 deficiency did not affect projection topography in
corticostriatal pathways. Anterograde tracing using CTb-Alexa
Fluor 488 revealed no defects of projection topography of
PCDH17/ striatal axons onto output nuclei (Figure S4D).
We also found that the PCDH10 expression pattern and
PCDH17 promoter-driven b-gal pattern were unaffected in
basal ganglia (Figures S4E and S4F). These findings strongly
suggested that PCDH17 is not involved in topographic map
formation along corticobasal ganglia circuits.
We then performed electron microscopic analysis of synap-
tic morphology in 3-week-old wild-type and PCDH17/ mice.
In excitatory asymmetric synapses of the anterior striatum,
where PCDH17 expression was evident, PCDH17 deficiency
caused significant increases in the number of docked SVs
and the total number of SVs per presynaptic terminal, whereas
in the posterior striatum where PCDH17 expression was weak,
these parameters did not exhibit significant changes (Figures
5A and 5B). Other parameters, such as average postsynaptic
spine area, PSD length, synaptic cleft width, and the density
of asymmetric synapses, were similar in wild-type and
PCDH17/ sections (Figures 5B and 5C). We also investigated
inhibitory symmetric synapses of the LGP as output nuclei
from the striatum. Increased numbers of docked SVs and total
SVs per presynaptic terminal were observed in the inner LGP,
but not in the outer LGP after PCDH17 ablation (Figures 5D
and 5E). Synaptic cleft width and density of symmetric synap-
ses were similar in both zones (Figures 5E and 5F). There were
no changes in synapse densities (Figures 5C and 5F) or the
expression of presynaptic proteins in PCDH17/ mice (Fig-
ure S3E). Only an increased number of docked SVs and total
SVs per presynaptic terminal were observed in PCDH17/
neurons. Taken together, PCDH17 appears to regulate presyn-
aptic SV assembly at both excitatory synapses on MSNs and
inhibitory synapses on LGP neurons in each zone-specific
region.Neuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc. 843
Figure 3. PCDH17 Is Localized at Perisynaptic Sites in Basal Ganglia
(A) 3D SIM imaging for PCDH17, VGLUT1, and PSD-95 in the anterior striatum of P14 mice.
(B) STORM imaging for PCDH17/VGLUT1 and PCDH17/PSD-95 in the anterior striatum of P14 mice.
(C) Pre-embedding immunogold electron microscopy for PCDH17 at asymmetric synapses in the anterior striatum of P14 mice.
(legend continued on next page)
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Protocadherin 17 in Corticobasal Ganglia CircuitsOverexpression of PCDH17 Results in Diffusion of
Synaptic Vesicle Puncta and Increases Mobility of
Presynaptic Clusters in Cultured Cortical Neurons
To evaluate the role of PCDH17 in SV assembly in vitro, we over-
expressed PCDH17 in cultured cortical neurons in concert with
synaptophysin-EGFP (Syn-EGFP), which is an SV marker used
to monitor SV assembly (Bamji et al., 2003). In the axons of con-
trol cells, Syn-EGFP exhibited rounded, punctate clusters. In
contrast, Syn-EGFP puncta that were originally associated with
PCDH17 puncta became more diffuse in PCDH17-overexpress-
ing neurons (Figures S5A and S5B), suggesting that expression
of PCDH17 inhibits the accumulation of SVs. Because inhibition
of SV assembly to the presynaptic terminal promotes SV cluster
movements (Bamji et al., 2003), we examined whether overex-
pression of PCDH17 affected the mobility of SV clusters. While
Syn-EGFP large puncta were stable or slow-moving in control
axons, Syn-EGFP large puncta were relatively mobile and ex-
hibited coordinated movement with PCDH17-mCherry puncta
in PCDH17-overexpressing axons (Figures S5C–S5E; Movies
S1 and S2). These findings demonstrate that PCDH17 clusters
aremobile elements and that PCDH17 overexpression promotes
the mobility of SV clusters along axons.
PCDH17–/– Mice Exhibit Altered Synaptic Transmission
Efficacy at Corticoanterior Striatal Synapses
To further characterize the role of PCDH17 in synaptic function,
we performed electrophysiological analysis of corticostriatal
synapses in acute slices. Since MSNs in the anterior portion of
the striatum strongly express PCDH17 (Figures 1D and 1E), we
made whole-cell recordings from MSNs in the anterior striatum
in wild-type and PCDH17/ mice of about three weeks of age.
To assess spontaneous synaptic transmission, we measured
miniature excitatory postsynaptic current (mEPSC). Both the fre-
quency and amplitude of mEPSCs in PCDH17/ MSNs were
comparable to those in wild-type MSNs (Figure 6A), suggesting
that the number of functional synapses is not altered in the
absence of PCDH17. We next analyzed the AMPA and NMDA
receptor-mediated components of evoked EPSCs. No signifi-
cant differences were observed in the 10%–90% rise time and
the decay time constant of either the AMPA or NMDA recep-
tor-mediated EPSCs between wild-type and PCDH17/ mice
(Figure S6A). Furthermore, the AMPA/NMDA ratio was not
altered in PCDH17/ mice, compared to wild-type mice (Fig-
ure 6B). These results indicate that basic properties of AMPA
and NMDA receptors at corticostriatal synapses and their rela-
tive contributions to corticostriatal synaptic transmission are
not altered in PCDH17/ mice.(D) (Left) Themean number of immunoparticles for PCDH17 per 1 mmof plasmame
(Right) Histogram for the tangential distribution of PCDH17 at asymmetric synap
(E) 3D SIM imaging for PCDH17, VGAT, and gephyrin in the inner LGP of P14 m
(F) STORM imaging for PCDH17/VGAT and PCDH17/gephyrin in the inner LGP o
(G) Pre-embedding immunogold electron microscopy for PCDH17 at symmetric
(H) (Left) The mean number of immunoparticles for PCDH17 per 1 mm of the plasm
tangential distribution of PCDH17 at symmetric synapses.
Boxed regions in (A) and (E) are enlarged on the right; orthogonal views of them
membrane is indicated in parentheses. The red bar indicates presynaptic distribu
shadow indicates the interior of synapses. Scale bars represent 2 mm (A and E
t, presynaptic terminal (red).To examine possible presynaptic changes in PCDH17/
mice, we next analyzed the paired-pulse ratio of evoked AMPA
receptor-mediated EPSCs at a range of interstimulus intervals.
We observed that the paired-pulse ratio exhibited a tendency
to increase in PCDH17/mice (Figure 6C). These results would
suggest thatPCDH17 deficiencymay affect presynaptic function
at corticostriatal synapses. However, post-hoc tests did not
reveal significant difference between genotypes at any pulse
interval. To test whether presynaptic function of GABAergic
inhibitory synapseswasaltered inPCDH17/mice,weanalyzed
the paired-pulse ratio of evoked inhibitory postsynaptic currents
(IPSCs) at anterior striatal-LGP synapses. We made whole-cell
recordings from neurons in the inner portion of the LGP where
PCDH17 was strongly expressed (Figures 1D and 1E) and stimu-
lated thecorrespondingportionof theanterior striatum.We found
that the paired-pulse ratio of IPSCswas significantly increased in
PCDH17/ mice at inter-pulse interval of 50 ms (Figure S6B),
although basic properties of GABA receptors were not changed
(Figure S6A). Taken together, these results suggest that
PCDH17 would be important for the presynaptic function in
both excitatory and inhibitory synapses in the basal ganglia.
We then assessed the recycling process of SVs in presynaptic
terminals by measuring synaptic depression induced by pro-
longed repetitive stimulation. Synaptic depression is reported
to reflect a presynaptic cycling process in which depleted
docked vesicles are replenished by reserve pool vesicles (Bamji
et al., 2003; Cabin et al., 2002). We applied repetitive stimulation
(10 Hz, 200 pulses) to corticostriatal fibers and measured the
amplitude of AMPA receptor-mediated EPSCs relative to that
of the first response (Figure 6D). Since repetitive stimulation
can release endocannabinoid 2-arachidonoyl glycerol from
MSNs (Kano et al., 2009; Maejima et al., 2005), we applied a
cannabinoid CB1 receptor antagonist to block the
endocannabinoid-mediated retrograde suppression of cortico-
striatal synapses and to evaluate unadulterated presynaptic
function. In wild-type and PCDH17/ mice at P21–P23, the
normalized EPSC amplitude decreased gradually during pro-
longed repetitive stimulation, but the depression of the normal-
ized EPSC amplitude was significantly weaker in PCDH17/
mice (Figure 6D). There was no significant difference in average
amplitudes of the first ten EPSCs between wild-type and
PCDH17/ mice (Figure S6A). Since the numbers of total SVs
was increased in PCDH17/ synapses at three weeks of age
(Figures 5A and 5B), the weaker synaptic depression following
repetitive stimulation is thought to result from the increased
number of vesicles available for release during enhanced
activity. In contrast, the extent of synaptic depression wasmbrane of presynaptic terminals, spines, and dendrites in the anterior striatum.
ses.
ice.
f P14 mice.
synapses in the inner LGP of P14 mice.
a membrane of presynaptic terminals and dendrites. (Right) Histogram for the
are shown to the right and bottom. (D and H) The length of analyzed plasma
tion and the blue bar indicates postsynaptic distribution of PCDH17. The gray
) and 200 nm (B, C, F, and G). Dn, dendrite (blue); Sp, dendritic spine (blue);
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Figure 4. PCDH17-Mediated Intercellular Homophilic Interaction
(A–C) Fc pull-down assays. (A) Diagram of PCDH17E-Fc, PCDH17-myc and PCDH10-myc. (B) Lysates of HEK293T cells expressing PCDH17-myc were sub-
jected to pull-down assays using PCDH17E-Fc in buffer containing the indicated concentrations of CaCl2 and EDTA (1 mM). (C) Lysates of HEK293T cells
expressing mock plasmids, PCDH10-myc and PCDH17-myc, were subjected to pull-down assays with PCDH17E-Fc in buffer containing 1 mMCaCl2. Amounts
of bound PCDH-myc, total PCDH-myc and loading PCDH17E-Fc were analyzed by immunoblotting.
(D) Immunofluorescence for PCDH17-myc and PCDH10-myc in confluent CHO cells stably expressing each protocadherin (left) and coculture of two stable CHO
cell lines (right).
(E) (Upper) Immunofluorescence for PCDH17-EGFP in 14 days in vitro (DIV) cortical neurons and PCDH17-myc (left) or PCDH10-myc (right) in CHO cells after
co-culture. Dashed white lines indicate the border of CHO cells. Higher-magnification images of PCDH17-EGFP signals are indicated on the bottom. (Lower)
Quantification of PCDH17-EGFP puncta in neurons that indicate close localization to PCDH17-myc or PCDH10-myc in CHO cells. At least 100 puncta were
counted for each condition from three separate cultures.
(F) Schematic representation of PCDH17 mediation of homophilic binding at an excitatory synapse and an inhibitory synapse.
Scale bars represent 20 mm (D) and 10 mm (E). Error bars indicate SEM. **p < 0.01; Student’s t test.
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ure S6C), suggesting that PCDH17’s regulation of synaptic
depression is developmental stage-dependent. Taken together,
these electrophysiological data suggest that overall synaptic
transmission efficacy is enhanced at anterior corticostriatal
excitatory synapses in PCDH17/ mice.
PCDH17–/– Mice Exhibit Antidepressant-like Behaviors
To examine behavioral abnormalities in PCDH17/ mice, we
performed a battery of behavioral tests for evaluating sensory846 Neuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc.andmotor functions, cognition, anxiety, and depression.We em-
ployed the tail suspension test and the forced swim test, which
are widely used for assessing antidepressant-like activity in
mice. In both tests, PCDH17/ mice were less immobile than
wild-type mice (Figures 7A and 7B), suggesting that PCDH17/
mice were less susceptible to depression than wild-type mice.
Alternatively, the reduced immobility of PCDH17/ mice in
these tests might have been caused by an increase in sponta-
neous activity (Cryan and Holmes, 2005). To check this
possibility, we performed the open field test to measure
Neuron
Protocadherin 17 in Corticobasal Ganglia Circuitsspontaneous locomotor activity of PCDH17/mice. The results
showed that there were no significant differences between wild-
type and PCDH17/mice in terms of immobility time, total dis-
tance traveled, or the amount of rearing activity observed during
the test (Figure 7C), suggesting that spontaneous activity was
normal in PCDH17/ mice. As alteration in fearfulness can
also affect performance in tests for depression (Cryan and
Holmes, 2005), we also analyzed anxiety-related behavior. We
did not detect any significant abnormalities in PCDH17/
mice in terms of ‘‘time spent in center areas’’ in the open field
test, ‘‘time spent in open arms’’ in the elevated plus-maze test,
or ‘‘time spent in the light box’’ in the light-dark transition test
(Figures 7C–7E), suggesting that the anxiety level of PCDH17/
mice is normal. Performance of PCDH17/mice also appeared
normal in the contextual fear conditioning test, auditory fear
conditioning test, acoustic startle response test, prepulse
inhibition test, and tail-flick test (Figure S7). Collectively,
PCDH17/ mice showed reduced susceptibility to depression,
but other general behaviors, such as locomotor activity, anxiety
behavior, fear learning, startle response, and pain behavior were
normal.
PCDH17 Is Topographically Expressed in Corticobasal
Ganglia Circuits of Primates
To better understand the possible functional role of PCDH17 in
human depressive disorders, it is important to analyze its
expression in primate brain. Here, we examined PCDH17 protein
expression in corticobasal ganglia circuits of infant rhesus
monkeys by immunostaining. Intense PCDH17 immunoreactivity
was generally observed in the frontal lobe and the striatum,
although the regional density differed among cortical areas or
striatal sectors (Figure 8A). In the frontal lobe, PCDH17 signals
were strong in the medial prefrontal cortex (area 32), the rostral
part of the anterior cingulate cortex (area 24), and the medial
part of the dorsolateral prefrontal cortex (area 9). PCDH17 sig-
nals were of intermediate strength in other prefrontal areas
(such as areas 46 and 11) and the motor-related areas (such
as areas 6 and 4). By contrast, PCDH17 immunoreactivity was
weak in the other (parietal and temporal) cortical areas that
include the somatosensory areas (areas 3 and 40) (Figures 8A
and 8B). Throughout the cortex, PCDH17 signals were apparent
in layers V and VI (Figure 8B). Thus, cortical PCDH17 expression
was rather specific to the frontal lobe, with a rostrocaudal
gradient. Likewise, PCDH17 immunoreactivity in the striatum
was found in both the caudate nucleus and the putamen with a
clear rostrocaudal gradient (Figure 8A). In addition, PCDH17
expression occurred in the external and internal segments of
the globus pallidus and the substantia nigra in a topographic
manner (Figure S8). These results indicate that the overall
expression pattern of PCDH17 in primates is largely consistent
with that in mice.
DISCUSSION
Topographically parallel organization is essential for information
processing along corticobasal ganglia circuits. In this study, we
showed that PCDH17 and PCDH10 display spatially comple-
mentary expression patterns along corticobasal ganglia circuits,suggesting that the expression of these protocadherins reflects
the topographic organization of the pathway. Then, using
PCDH17/mice, we demonstrated that PCDH17 regulates pre-
synaptic vesicle assembly and synaptic transmission efficacy in
corticostriatal pathways. Finally, we found that PCDH17/mice
display less depression-like behavior, and that they manifested
normal sensorimotor and cognitive functions and anxiety level,
suggesting that PCDH17 is specifically involved in depression-
related behavior.
Based on neuroanatomical and neuroimaging studies in pri-
mates, an anteroposterior gradient of corticostriatal connec-
tions has been proposed (Draganski et al., 2008). Specifically,
neurons in prefrontal cortical areas, including the medial pre-
frontal cortex, project to anterior regions of the striatum, sen-
sory, and motor cortical neurons to central dorsolateral regions,
and parietal cortical neurons to more caudal regions, forming
the limbic and associative loops, the sensorimotor loop, and
the perceptual loop, respectively. Because PCDH17 was mostly
expressed along the medial prefrontal cortex-anterior striatal
pathways in a topographic manner, in both rodents and pri-
mates, it is likely that PCDH17 is anatomically and functionally
conserved in the corticobasal ganglia circuits of higher primates
as well. Therefore, the PCDH17-expressing neuronal pathway
could correspond to the prefrontal cortical loops in primates
used for processing some aspects of motivational and execu-
tive functions.
As the complementary expression patterns of PCDH17 and
PCDH10 appear at E14.5 and gradually develop in the embry-
onic mouse striatum until birth (our unpublished data), we
assumed that the expression of these protocadherins was recip-
rocally regulated by positional information in the embryonic
striatum. Nevertheless, PCDH17 is dispensable in this topo-
graphic map formation (Figure S4), although it has crucial roles
in the synaptic development of this pathway. In addition to these
protocadherins, some axon guidance molecules that are
involved in topographic map formation in the visual and olfactory
systems (Luo and Flanagan, 2007; Sakano, 2010), are also ex-
pressed in the embryonic striatum in a zone-specific manner.
Like PCDH17, Netrin-1 exhibits an expression pattern with a
high-anterior to low-posterior gradient in embryonic striatal
regions (Powell et al., 2008). In contrast, similar to PCDH10,
Ephrin-A5 and Semaphorin-3A exhibit expression patterns
with low-anterior to high-posterior gradients (Dufour et al.,
2003; Wright et al., 2007). Therefore, these axon guidance
molecules might organize the topographic map delineated by
PCDH17 and PCDH10 expression in the embryonic basal
ganglia.
PCDH10/ mice exhibit axonal growth defects in the stria-
tum and die within the first several weeks after birth (Uemura
et al., 2007), whereas PCDH17/ mice do not die prematurely
and are not characterized by abnormal striatal axonal growth.
These phenotypic differences may be at least partially attrib-
utable to different protein distributions in embryonic striatal
fibers; PCDH10 (Uemura et al., 2007), but not PCDH17 (our un-
published data), is distributed around striatal fibers at E14.5. It
should be noted that similar to that of PCDH17, the expression
of PCDH10 peaks during early synaptogenesis. A recent paper
showed that PCDH10 is required for activity-dependentNeuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc. 847
(legend on next page)
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Therefore, PCDH10 may function not only in axonal growth,
but also in synaptic development of corticobasal ganglia cir-
cuits. Conditional depletion of PCDH10 would be informative
in elucidating its possible roles in synaptic development in
that circuit.
What are the molecular mechanisms by which PCDH17 reg-
ulates SV assembly in developmental synapses? One report
showed that homophilic interactions of PCDH8, in cis or trans,
decrease dendritic spine density (Yasuda et al., 2007). Evi-
dence that PCDH17 mediates intercellular homophilic interac-
tions and is localized at perisynaptic sites may imply that
homophilic interactions of PCDH17 regulate SV assembly in
presynaptic terminals, although the cellular and molecular
mechanisms need to be clarified. Several lines of evidence
demonstrate that the N-cadherin-b-catenin adhesion complex
plays a central role in recruiting SVs to presynaptic terminals
(Arikkath and Reichardt, 2008). SV clusters are surrounded by
actin filaments, suggesting that localization of SVs is dependent
upon F-actin (Bamji 2005). Thus, the N-cadherin-b-catenin
complex and its associated F-actin regulation are thought to
play a part in presynaptic SV assembly. Given that some
d-protocadherin members, such as PCDH8 and PCDH10, act
as negative regulators of N-cadherin (Nakao et al., 2008;
Yasuda et al., 2007), it is likely that PCDH17 also perturbs the
function of the N-cadherin-b-catenin complex and inhibits SV
assembly forces. Furthermore, as the cytoplasmic domain of
PCDH17, like that of PCDH10 and PCDH19, interacts with the
WAVE complex (our unpublished data; Nakao et al., 2008; Tai
et al., 2010), PCDH17-WAVE complex machinery might affect
the N-cadherin-b-catenin complex and its associated actin
cytoskeleton, resulting in delocalization of SVs in presynaptic
terminals. Further detailed analyses are required for clarification
of the role of PCDH17 in SV assembly.
The abundance and localization of presynaptic SVs are crit-
ical for regulation of synaptic physiology. In N-cadherin and
b-catenin knockout synapses, the response with respect to
the EPSC amplitude during repetitive stimulation is signifi-
cantly smaller, suggesting that the cadherin-catenin complex
positively regulates the availability of SVs for release during
high activity (Bamji et al., 2003; Ju¨ngling, et al., 2006). Consid-
ering the possible negative regulation of N-cadherin by d-pro-
tocadherins (Nakao et al., 2008; Yasuda et al., 2007),
increased numbers of SVs in PCDH17 knockout synapses
could contribute to the ready availability of SVs for neurotrans-
mitter release. This idea is supported by our electrophysiolog-
ical data that PCDH17 knockout synapses exhibited lessFigure 5. Increased Synaptic Vesicle Number at Presynaptic Terminals
(A) Electron microscopic images of the anterior and posterior striatum of 3-week
(B) Quantification of asymmetric synapses (docked SV number, total SV number, s
were counted per genotype from three mouse pairs.
(C) Quantification of synapse number in 1,300 mm2 of the striatum per genotype
(D) Electron microscopic images of the inner and outer LGP of 3-week-old PCDH
(E) Quantification of symmetric synapses (docked SV number, total SV number,
mouse pairs.
(F) Quantification of synapse number in 1,300 mm2 of the LGP for each genotype
Scale bars represent 200 nm. Error bars indicate SEM. **p < 0.01; ***p < 0.001;synaptic depression following repetitive stimulation of input
fibers. It is assumed that paired-pulse depression is affected
by SV transitions in the pools as well as by neurotransmitter
release probability (Regehr, 2012). It might be possible that
PCDH17 deficiency decreases paired-pulse depression as a
result of higher vesicle replenishment into release sites.
Although it is also possible that the presynaptic release prob-
ability is changed at PCDH17 knockout synapses, the precise
roles of PCDH17 in presynapses need to be analyzed in future
studies. In addition to its regulatory role in presynaptic func-
tion, PCDH17 may have additional roles in postsynaptic func-
tion considering the both pre- and postsynaptic localization of
PCDH17.
Our observation that loss of PCDH17 affects depression-
related behaviors might suggest that altered synaptic function
in the aforementioned PCDH17-expressing corticobasal ganglia
circuits could play an important role in depressive behaviors.
Accordingly, dysregulated functional activity within an extended
network, including medial prefrontal cortex and striatum, is a key
symptom of depression in humans (Krishnan and Nestler, 2008;
Price and Drevets, 2012). Optogenetic stimulation of the medial
prefrontal cortex-mediated pathways in rodents is reported to
control depression-related behaviors (Covington et al., 2010;
Warden et al., 2012). Furthermore, our hypothesis may be sup-
ported by evidence that PCDH17 is strongly expressed in the
primate prefrontal cortical area and associated regions that are
most crucial for depression. Although PCDH17 was also ex-
pressed in amygdala, hypothalamus, and other mesolimbic
areas, future studies with neural pathway-specific PCDH17 con-
ditional knockout mice could clarify the possible relationship
between topographic corticobasal ganglia circuits and depres-
sion-related behaviors. Moreover, it will be of considerable
importance to search for mutations in PCDH17 in human mood
disorders.EXPERIMENTAL PROCEDURES
Detailed experimental procedures are provided in the Supplemental Informa-
tion. Experiments were conducted according to the institutional ethical guide-
lines for animal experiments.Generation of PCDH17–/– Mice
Details can be found in Supplemental Experimental Procedures.Intracranial Surgery
Intracranial surgery was performed as previously described (Fukabori et al.,
2012).in the Topographic Basal Ganglia Pathways of PCDH17–/– Mice
-old PCDH17+/+ and PCDH17/ mice.
ynaptic cleft, spine area, and PSD length) in the striatum. At least 240 synapses
from three mouse pairs.
17+/+ and PCDH17/ mice.
synaptic cleft). At least 240 synapses were counted per genotype from three
from three mouse pairs.
Student’s t test; SV, synaptic vesicle. See also Figures S3, S4, and S5.
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Figure 6. Altered Short-TermSynaptic Plas-
ticity at Corticoanterior Striatal Synapses in
PCDH17–/– Mice
(A) (Left) Representative traces of mEPSCs from
anterior MSNs of 3-week-old PCDH17+/+ and
PCDH17/ mice. (Right) Summary bar graphs
showing average mEPSC amplitude and fre-
quency (n = 13 for PCDH17+/+ and n = 14 for
PCDH17/ mice).
(B) (Left) Representative traces of AMPA and
NMDA receptor-mediated EPSCs from anterior
MSNs elicited by stimulation of corticostriatal af-
ferents in 3-week-old PCDH17+/+ and PCDH17/
mice. AMPA and NMDA EPSCs were recorded at
a holding potential of 70 mV and +50 mV,
respectively. (Right) Summary bar graph showing
ratios of NMDA to AMPA EPSC amplitudes (n = 25
for PCDH17+/+ and n = 23 for PCDH17/ mice).
Amplitudes of AMPA EPSCs were measured at
their peaks (leftward arrowheads), whereas those
of NMDA EPSCsweremeasured at 60ms from the
stimuli (downward arrowheads).
(C) (Left) Representative traces of AMPA receptor-
mediated EPSCs to paired stimuli of 70 ms interval
from anterior MSNs of 3-week-old PCDH17+/+
and PCDH17/ mice. (Right) Summary graph
showing ratios of second to first EPSC amplitudes
as a function of interstimulus interval (20, 30, 50
70, 100, and 200ms) (n = 25 forPCDH17+/+ and n =
29 for PCDH17/ mice). There was a significant
main effect of genotype (p < 0.01; two-way
ANOVA), although post-hoc tests did not reveal
significant difference between genotypes at any
pulse interval.
(D) (Upper) Representative traces of EPSCs from
anterior MSNs of 3-week-old PCDH17+/+ and
PCDH17/ mice during prolonged repetitive
stimulation (10 Hz, 200 pulses). Only responses
1–3 (black) and 51–53 (red) are shown. (Lower)
Summary graph showing average normalized
response amplitudes of EPSCs (n = 12 for
PCDH17+/+ and n = 9 for PCDH17/ mice). Each
point represents the average of 10 consecutive
responses.
Calibration bars = 10 pA and 200 ms (A), 0.4 nA
and 20 ms (B), 0.1 nA and 20 ms (C), 0.1 nA and
50 ms (D). Error bars indicate SEM. *p < 0.05;
Mann-Whitney U-test (A and B), two-way
repeated-measures ANOVA (D). See also Fig-
ure S6.
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Figure 7. Antidepression-like Behaviors in PCDH17–/– Mice
(A) Tail suspension test. (Left) Immobility time was measured for 6 min. (Right) Cumulative immobility time during the last 4 min of the 6 min test session (n = 8 for
PCDH17+/+ and n = 12 for PCDH17/ mice).
(B) Forced swim test. (Left) Immobility time wasmeasured for 10 min. (Right) Cumulative immobility time during the last 6 min of the 10min test session (n = 19 for
PCDH17+/+ and n = 21 for PCDH17/ mice).
(C) Open field test. Immobility time, total distance traveled, rearing number and time spent in center areas were measured (n = 8 for PCDH17+/+ and n = 12 for
PCDH17/ mice).
(D) Elevated plusmaze test. Time spent per compartment (open arms [O] or closed arms [C]) wasmeasured (n = 8 forPCDH17+/+ and n = 12 forPCDH17/mice).
(E) Light-dark emergence test. Time spent per compartment (lighted areas [L] or dark areas [D]) was measured (n = 11 for PCDH17+/+ and n = 9 for PCDH17/
mice).
Error bars indicate SEM. *p < 0.05; Student’s t test. See also Figure S7.
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Experiments, and Immunocytochemistry
Neuronal culture was performed as previously described (Nakazawa et al.,
2008). Details can be found in Supplemental Experimental Procedures.
Fc Pull-Down Assay
The Fc pull-down assay was performed as previously described (Kazmierczak
et al., 2007).
Histology
X-gal staining, fluorescent in situ hybridization, immunohistochemistry,
STORM imaging, pre-embedding immunogold electron microscopy,Nissl staining, and immunohistochemistry in rhesus monkey brain
were basically performed as described (Dani et al., 2010; Lu
et al., 2012; Takeuchi et al., 2010; Taniguchi et al., 2009; Yamasaki
et al., 2010).
Time-Lapse Live Imaging
Time-lapse imaging analysis was performed as previously described
(Oshimori et al., 2009).
Electron Microscopy
Transmission electron microscopy analysis was performed as previously
described (Goto et al., 2008).Neuron 78, 839–854, June 5, 2013 ª2013 Elsevier Inc. 851
Figure 8. Expression Pattern of PCDH17 in Monkey Brain
Immunostaining for PCDH17 in coronal sections taken from a 2-month-old rhesus monkey. Each number indicates Brodmann’s area.
(A) Overview of PCDH17 expression along the rostrocaudal axis.
(B) Higher-magnification images of cortical areas specified in (A).
Scale bars represent 5 mm (A) and 0.5 mm (B). Cd, caudate nucleus; GPe, external segment of the globus pallidus; GPi, internal segment of the globus pallidus;
HTh, hypothalamus; NA, nucleus accumbens; Put, putamen; Th, thalamus; WH, white matter; 3, primary somatosensory cortex (S1); 4, primary motor cortex
(M1); 6, premotor cortex (PM); 9, 46, dorsolateral prefrontal cortex (DLPFC); 11, orbitofrontal cortex (OFC); 24, anterior cingulate cortex (ACC); 32, medial
prefrontal cortex (mPFC); 40, secondary somatosensory cortex (S2). See also Figure S8.
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Whole-cell patch-clamp recordings were performed as previously described
(Tanimura et al., 2010).
Behavioral Tests
All behavioral experiments were performed as blind tests. Male mice,
7–9 weeks of age, were analyzed for all experiments as previously described
(Taniguchi et al., 2009).
SUPPLEMENTAL INFORMATION
Supplemental Information includes eight figures, two movies, and Supple-
mental Experimental Procedures and can be found with this article online at
http://dx.doi.org/10.1016/j.neuron.2013.03.031.
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